Introduction
Objective Methods Atrial Fibrillation (AF) is the most common form of arrhythmia affecting 1.8% of the adult Scottish population and rising to 6% in individuals aged over 65 years.
Atrial Fibrillation (AF) is often linked to stroke, and incurs significant clinical and economic burden to both the patient and the NHS. Oral anticoagulants (OAC) are commonly prescribed for AF patients for the prevention of stroke.
Previous studies have estimated the cost of hospitalisations associated with AF.
This study seeks to estimate prescribing, inpatient, outpatient and social care costs associated with AF in a Scottish cohort, by using individual-level linked data.
Conclusions
■ A cohort of patients 50 years and older, hospitalised with a known diagnosis of AF or atrial flutter between 1997 and 2014, was followed up for five years following the first AF event.
■ Individual-level data on hospitalisation and discharge to social care home were obtained from the Scottish Morbidity Records (SMR01); these were linked to outpatient data (SMR00), prescribing data (Scottish Prescribing Information System; PIS) and death records. The mean cost per patient was estimated to be £3, 874 (95% CI 3, 855; 3, 892) . Hospital is the main cost driver, care home costs increase significantly with age. Overall, hospital admissions and outpatient visits accounted for 76.6% and 5.4% of the total cost, respectively; social care and prescriptions accounted for 13.6% and 3.9% of the total cost. The youngest patients incur the highest estimated total costs. Patients ≥90 years incurred significantly lower costs than those in younger age groups. For these patients, a significant reduction of hospital costs alongside an increase in social care costs was observed.
■ Figure 3 : Overall, patients with multi-comorbidities incurred 26.5% and 44.5% higher total costs then those with one comorbidity or no comorbidities. For each group, the contribution of each setting to the total cost remained unchanged. 
